Skip to main content
Clinical Trials/IRCT20210209050313N1
IRCT20210209050313N1
Not yet recruiting
Phase 3

Comparison of triple treatment regimen containing levofloxacin with triple treatment regimen containing clarithromycin in the first line of treatment of patients with Helicobacter pylori infection referred to the clinic of Imam Khomeini Hospital during 2021-2022.

Tehran University of Medical Sciences0 sites130 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Helicobacter pylori infection.
Sponsor
Tehran University of Medical Sciences
Enrollment
130
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Confirmation of the presence of H.pylori by fecal antigen test

Exclusion Criteria

  • History of previous treatment for eradication of Helicobacter pylori
  • Age less than 18 years and over 65 years
  • History of allergy or severe reaction to drugs used in the plan
  • History of major surgery on the gastrointestinal tract such as bilirut and bypass and gastrogenostomy And gastrectomy
  • Severe underlying disease such as liver failure) Cirrhosis of the liver (or kidney) Creatinine above 2 (or proven malignancy Untreated active
  • Active pregnancy or lactation
  • Inability to follow up
  • Use of proton pump inhibitors And antibiotics in the last 4 weeks
  • Contraindications to the use of prescription drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials